This bill amends various sections of the Minnesota Statutes concerning the regulation of medical cannabis and the cannabis industry, primarily by replacing the term "commissioner" with "office," indicating a shift in oversight to the Office of Cannabis Management. Key updates include the redefinition of "health care practitioner" to ensure they are Minnesota-licensed and operating within their professional scope. The bill also clarifies the responsibilities of the office in managing medical cannabis manufacturers, including registration, compliance, and reporting requirements, while emphasizing patient safety and the need for comprehensive information on the therapeutic use of medical cannabis.

Additionally, the bill introduces a cannabis microbusiness license, allowing holders to engage in activities related to cannabis and hemp products, and establishes new testing and labeling requirements for cannabis products to enhance consumer safety. It mandates thorough testing for contaminants and updates labeling standards to include essential product information. The bill also includes provisions for financial audits of manufacturers, the establishment of a sliding scale for patient fees, and the protection of patient data. Overall, the legislation aims to strengthen the regulatory framework for cannabis in Minnesota, ensuring better oversight, compliance, and consumer protection.

Statutes affected:
Introduction: 152.22, 152.24, 152.25, 152.26, 152.261, 152.27, 152.28, 152.29, 152.31, 152.32, 152.33, 152.35, 152.37, 342.01, 342.02, 342.12, 342.14, 342.151, 342.22, 342.28, 342.29, 342.30, 342.33, 342.44, 342.46, 342.52, 342.57, 342.59, 342.61, 342.63